[96a5a0]: / output / allTrials / identified / NCT06205173_identified.json

Download this file

295 lines (295 with data), 12.6 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
{
"info": {
"nct_id": "NCT06205173",
"official_title": "Explored About Temperature Packing Care to Improve the Quality of Life for Chemotherapy Induced Peripheral Neuropathy (CIPN) in Colorectal Cancer and Gastric Cancer Patient",
"inclusion_criteria": "* Individuals aged 20 and above, inclusive, can autonomously decide to participate in this study and complete the Participant Consent Form.\n* Patients diagnosed with colorectal cancer, receiving chemotherapy for the first time, and being prescribed the standard FOLFOX regimen with Oxaliplatin as the primary agent are eligible. The dosage is 85mg/m2 administered over a 2-hour injection every 14 days, constituting one treatment cycle. A total of 6 treatment cycles will be conducted.\nHealthy volunteers allowed\nMust have minimum age of 20 Years",
"exclusion_criteria": "* Individuals with an undiagnosed medical condition.\n* Individuals with thyroid disorders, diabetes, undergoing dialysis, pregnant, alcohol abusers, and those with immune-related diseases such as lupus erythematosus, scleroderma, dermatomyositis, and rheumatoid arthritis are excluded from the study..\n* Individuals with defects in hands, feet, or fingers.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Individuals aged 20 and above, inclusive, can autonomously decide to participate in this study and complete the Participant Consent Form.",
"criterions": [
{
"exact_snippets": "Individuals aged 20 and above, inclusive",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 20,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "autonomously decide to participate",
"criterion": "autonomous decision-making ability",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "complete the Participant Consent Form",
"criterion": "completion of Participant Consent Form",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients diagnosed with colorectal cancer, receiving chemotherapy for the first time, and being prescribed the standard FOLFOX regimen with Oxaliplatin as the primary agent are eligible. The dosage is 85mg/m2 administered over a 2-hour injection every 14 days, constituting one treatment cycle. A total of 6 treatment cycles will be conducted.",
"criterions": [
{
"exact_snippets": "Patients diagnosed with colorectal cancer",
"criterion": "colorectal cancer diagnosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "receiving chemotherapy for the first time",
"criterion": "chemotherapy history",
"requirements": [
{
"requirement_type": "history",
"expected_value": "first time"
}
]
},
{
"exact_snippets": "being prescribed the standard FOLFOX regimen",
"criterion": "chemotherapy regimen",
"requirements": [
{
"requirement_type": "type",
"expected_value": "standard FOLFOX"
}
]
},
{
"exact_snippets": "with Oxaliplatin as the primary agent",
"criterion": "primary chemotherapy agent",
"requirements": [
{
"requirement_type": "type",
"expected_value": "Oxaliplatin"
}
]
},
{
"exact_snippets": "The dosage is 85mg/m2 administered over a 2-hour injection every 14 days",
"criterion": "Oxaliplatin dosage",
"requirements": [
{
"requirement_type": "dosage",
"expected_value": {
"operator": "=",
"value": 85,
"unit": "mg/m2"
}
},
{
"requirement_type": "administration duration",
"expected_value": {
"operator": "=",
"value": 2,
"unit": "hour"
}
},
{
"requirement_type": "administration frequency",
"expected_value": "every 14 days"
}
]
},
{
"exact_snippets": "A total of 6 treatment cycles will be conducted",
"criterion": "treatment cycles",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "=",
"value": 6,
"unit": "cycles"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 20 Years",
"criterions": [
{
"exact_snippets": "minimum age of 20 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 20,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Individuals with an undiagnosed medical condition.",
"criterions": [
{
"exact_snippets": "undiagnosed medical condition",
"criterion": "medical condition",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": false
}
]
}
]
},
{
"line": "* Individuals with thyroid disorders, diabetes, undergoing dialysis, pregnant, alcohol abusers, and those with immune-related diseases such as lupus erythematosus, scleroderma, dermatomyositis, and rheumatoid arthritis are excluded from the study..",
"criterions": [
{
"exact_snippets": "thyroid disorders",
"criterion": "thyroid disorders",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "diabetes",
"criterion": "diabetes",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "undergoing dialysis",
"criterion": "dialysis",
"requirements": [
{
"requirement_type": "undergoing",
"expected_value": false
}
]
},
{
"exact_snippets": "pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
},
{
"exact_snippets": "alcohol abusers",
"criterion": "alcohol abuse",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "immune-related diseases such as lupus erythematosus, scleroderma, dermatomyositis, and rheumatoid arthritis",
"criterion": "immune-related diseases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "* Individuals with defects in hands, feet, or fingers.",
"criterions": [
{
"exact_snippets": "defects in hands",
"criterion": "defects in hands",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "defects in feet",
"criterion": "defects in feet",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "defects in ... fingers",
"criterion": "defects in fingers",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"failed_miscellaneous": []
}